ExploreWatchlistsPricing
  1. JP-listed companies
  2. KISSEI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Payments for dividends

KISSEI PHARMACEUTICAL CO.,LTD. (4547)

Market cap
¥230.7B
P/E ratio
15.8x
Kissei Pharmaceutical develops and manufactures prescription drugs while also operating subsidiaries in food products, IT services, and construction.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndPayments for dividends (Million JPY)YoY (%)
Mar 31, 2025-3,801+2.12%
Mar 31, 2024-3,722+18.72%
Mar 31, 2023-3,135+23.62%
Mar 31, 2022-2,536+2.46%
Mar 31, 2021-2,475+3.90%
Mar 31, 2020-2,382+4.06%
Mar 31, 2019-2,289+0.84%
Mar 31, 2018-2,270+3.13%
Mar 31, 2017-2,201+4.66%
Mar 31, 2016-2,103-0.33%
Mar 31, 2015-2,110

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat